Genomic loss of PTEN (hemi- and homozygous deletion) was associated with high-grade malignancy (P<0.001), lymph node metastases (P<0.001) and advanced (III, IV) tumour stage (P=0.002). The gene discussed is PTEN; the disease is neoplasm.